These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 27050667)
1. Lowering methodological standards for studies of multidrug-resistant bacteria is counterproductive. Paul M; Hussein K Clin Microbiol Infect; 2016 Jun; 22(6):497-8. PubMed ID: 27050667 [No Abstract] [Full Text] [Related]
2. Late stage antibacterial drugs in the clinical pipeline. Projan SJ; Bradford PA Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658 [TBL] [Abstract][Full Text] [Related]
4. Difficulties in demonstrating superiority of an antibiotic for multidrug-resistant bacteria in nonrandomized studies. Stafford KA; Boutin M; Evans SR; Harris AD Clin Infect Dis; 2014 Oct; 59(8):1142-7. PubMed ID: 24982037 [TBL] [Abstract][Full Text] [Related]
6. Studying new antibiotics for multidrug resistant infections: are today's patients paying for unproved future benefits? Powers JH; Evans SR; Kesselheim AS BMJ; 2018 Feb; 360():k587. PubMed ID: 29472192 [No Abstract] [Full Text] [Related]
7. [Microbiological approach to antibiotic therapy against multidrug-resistant bacteria]. Kusachi S Nihon Geka Gakkai Zasshi; 2003 Jul; 104(7):527-9. PubMed ID: 12884778 [TBL] [Abstract][Full Text] [Related]
8. The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents. Payne D; Tomasz A Curr Opin Microbiol; 2004 Oct; 7(5):435-8. PubMed ID: 15451496 [No Abstract] [Full Text] [Related]
9. Selecting empiric antibiotic therapy in an era of multi-drug resistance--is the cupboard really bare? Introduction. Collatz E Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():1. PubMed ID: 19040460 [No Abstract] [Full Text] [Related]
11. [Fosfomycin--its significance for treatment of diseases due to multidrug-resistant bacteria]. Stock I Med Monatsschr Pharm; 2015 Jan; 38(1):4-11. PubMed ID: 26349119 [TBL] [Abstract][Full Text] [Related]
12. Challenges in the management of serious infections. Rehm SJ; Bartlett JG Clin Infect Dis; 2006 Jan; 42 Suppl 2():S63-4. PubMed ID: 16355318 [No Abstract] [Full Text] [Related]
13. New β-lactam antibiotics and β-lactamase inhibitors. Bush K; Macielag MJ Expert Opin Ther Pat; 2010 Oct; 20(10):1277-93. PubMed ID: 20839927 [TBL] [Abstract][Full Text] [Related]
15. Novel antibiotics: are we still in the pre-post-antibiotic era? Draenert R; Seybold U; Grützner E; Bogner JR Infection; 2015 Apr; 43(2):145-51. PubMed ID: 25701222 [TBL] [Abstract][Full Text] [Related]
17. Metal nanobullets for multidrug resistant bacteria and biofilms. Chen CW; Hsu CY; Lai SM; Syu WJ; Wang TY; Lai PS Adv Drug Deliv Rev; 2014 Nov; 78():88-104. PubMed ID: 25138828 [TBL] [Abstract][Full Text] [Related]